Calcitonin elevation in small cell lung cancer without ectopic production.

To determine the relative contribution of ectopic calcitonin (CT) production versus nonectopic secretion of CT in patients with small cell lung cancer (SCLC), serum and urine immunoreactive CT (iCT) levels of 86 different subjects were measured by radioimmunoassay (RIA) using two polyclonal antisera (Ab3b and Ab4). The subjects included 49 previously untreated patients with SCLC, 17 smokers, and 20 nonsmokers. Serum and urine iCT values were highest in the patients with SCLC, intermediate in the smokers, and lowest in the nonsmokers (p < 0.0003). Sixteen of the 49 patients with SCLC had tumor cell lines available for determination of CT mRNA expression by RNase protection assay (RPA) and iCT production by RIA. CT mRNA was detected in nine of 16 subjects and iCT in eight of 16. The tumor cell lines of seven patients had undetectable CT by both RPA and RIA, and of these, five had elevated urine or serum iCT values compared with those of nonsmokers, and two had levels above all values in the smoker group. Immunohistochemical staining of formalin-fixed, paraffin-embedded tumor samples detected iCT in two of four tumors from patients whose tumor cell lines had CT mRNA by RPA and iCT by RIA, but in none of six whose tumor cell lines had undetectable CT mRNA. Thus, increased iCT values in some patients with SCLC are likely due to sources other than CT production by tumor cells.

[1]  S. Bates,et al.  Clinical applications of serum tumor markers. , 1991, Annals of internal medicine.

[2]  Y. Miller,et al.  Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. , 1989, The Journal of clinical investigation.

[3]  Y. Tsutsumi.  Immunohistochemical analysis of calcitonin and calcitonin gene-related peptide in human lung. , 1989, Human pathology.

[4]  K. Becker,et al.  Stimulation of hamster pulmonary neuroendocrine cells and associated peptides by repeated exposure to cigarette smoke. , 1989, The American review of respiratory disease.

[5]  D. O'Connor,et al.  Demonstration of chromogranin a in human neuroendocrine cell lines by immunohistology and immunoassay , 1988, Cancer.

[6]  R. Makuch,et al.  Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. , 1987, Annals of internal medicine.

[7]  N. Anthonisen,et al.  Airways obstruction and the risk for lung cancer. , 1987, Annals of internal medicine.

[8]  K P Offord,et al.  Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. , 1986, Annals of internal medicine.

[9]  Y. Matsuoka,et al.  Production of immunoreactive calcitonin and some other tumor markers by established human carcinoma cell lines. , 1986, Japanese journal of cancer research : Gann.

[10]  L. Faling.  THE ENDOCRINE LUNG IN HEALTH AND DISEASE , 1985 .

[11]  G. Bepler,et al.  Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.

[12]  G. Sorenson,et al.  Expression of the human calcitonin/CGRP gene in lung and thyroid carcinoma. , 1985, The EMBO journal.

[13]  S. Baylin,et al.  Structure and expression of a gene encoding human calcitonin and calcitonin gene related peptide. , 1984, Biochemical and biophysical research communications.

[14]  A. Gazdar,et al.  Calcitonin secretion by continuous cultures of small cell carcinoma of the lung: incidence and immunoheterogeneity studies. , 1983, Cancer letters.

[15]  S. Wallach,et al.  Plasma calcitonin as a marker of disease activity in patients with small cell carcinoma of the lung. , 1981, The Journal of clinical endocrinology and metabolism.

[16]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  K. Becker,et al.  Increased serum and urinary calcitonin levels in patients with pulmonary disease. , 1981, Chest.

[18]  K. Becker,et al.  Immunocytochemical localization of calcitonin in Kulchitsky cells of human lung. , 1980, Archives of pathology & laboratory medicine.

[19]  K. Becker,et al.  Urine calcitonin levels in patients with bronchogenic carcinoma. , 1980, JAMA.

[20]  K. Becker,et al.  Urine Calcitonin as a Test for Medullary Thyroid Cancer: A New Screening Procedure , 1979, Annals of surgery.

[21]  J. Doppman,et al.  Increased serum calcitonin levels in bronchogenic cancer. , 1976, Chest.

[22]  C. Byus,et al.  Ribonucleic acid isolated by cesium chloride centrifugation. , 1974, Biochemistry.

[23]  K. Becker,et al.  Radioimmunoassay of calcitonin in human plasma. , 1974, Clinical chemistry.

[24]  D. Cox,et al.  The analysis of binary data , 1971 .

[25]  S. Steinberg,et al.  Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium. , 1993, Cancer research.

[26]  L. Breimer,et al.  The calcitonin gene peptides: biology and clinical relevance. , 1990, Critical reviews in clinical laboratory sciences.

[27]  T. Ito,et al.  Production of bronchial papilloma with calcitonin-like immunoreactivity in rats exposed to urban ambient air. , 1989, Experimental pathology.

[28]  M H Gail,et al.  Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer. , 1986, Journal of the National Cancer Institute.

[29]  M. Zweig,et al.  Expression of peptide and other markers in lung cancer cell lines. , 1985, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[30]  J. Hájek.  A course in nonparametric statistics , 1969 .